Article info

Download PDFPDF

Response to: ‘Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease’ by Campochiaro et al

Authors

  • Fleur Cohen-Aubart Sorbonne Université, Assistance Publique Hôpitaux de Paris, Service de Médecine Interne 2, Hôpital de la Pitié-Salpêtrière, Centre National de Référence Lupus Systémique et Histiocytoses, Paris, France PubMed articlesGoogle scholar articles
  • Neila Benameur Assistance Publique Hôpitaux de Paris, Département de Pharmacie, Hôpital de la pitié-Salpêtrière, Paris, France PubMed articlesGoogle scholar articles
  • Zahir Amoura Sorbonne Université, Assistance Publique Hôpitaux de Paris, Service de Médecine Interne 2, Hôpital de la Pitié-Salpêtrière, Centre National de Référence Lupus Systémique et Histiocytoses, Paris, France PubMed articlesGoogle scholar articles
  • Julien Haroche Sorbonne Université, Assistance Publique Hôpitaux de Paris, Service de Médecine Interne 2, Hôpital de la Pitié-Salpêtrière, Centre National de Référence Lupus Systémique et Histiocytoses, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Fleur Cohen-Aubart, AP-HP, Hôpital de la Pitié-Salpêtrière, Service de Médecine Interne 2, Sorbonne Université Faculté de Médecine, Paris, Île-de-France 75013, France; fleur.cohen{at}psl.aphp.fr
View Full Text

Citation

Cohen-Aubart F, Benameur N, Amoura Z, et al
Response to: ‘Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease’ by Campochiaro et al

Publication history

  • Received December 31, 2019
  • Revised January 2, 2020
  • Accepted January 7, 2020
  • First published January 20, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.